Evidence map›Paper›PMID 14713106›Full record

ArticleClinical & experimental metastasis2003

Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype.

Michelle L Varney, Aihua Li, Bhavana J Dave, Corazan D Bucana, Sonny L Johansson, Rakesh K Singh

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Anti-Cancer Effects ofMolecules (Basel, Switzerland) · 2020
    Article
  4. Article
  5. Review
  6. Novel adherent CD11bOncotarget · 2018
    Article
  7. Article
  8. Article
  9. High risk of development of renal cell tumor in end-stage kidney disease: the role of microenvironment.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  10. Article
  11. Article
  12. Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.International journal of clinical and experimental pathology · 2015
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michelle L VarneyDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198-7660, USA.
Aihua Li
Bhavana J Dave
Corazan D Bucana
Sonny L Johansson
Rakesh K Singh
University of Nebraska Medical Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

Molecular Regulation of Human Melanoma MetastasisR01CA072781 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SINGH, RAKESH K · 2005 to 2007
$580k
MOLECULAR REGULATION OF HUMAN MELANOMA METASTASISR29CA072781 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SINGH, RAKESH K · 1998 to 2002
$308k
NCI NIH HHS CA72781
6 · The paper itself

Abstract

In the present study, we examined the autocrine/paracrine role of IL-8 in melanoma growth and metastasis by analyzing the expression and functional significance of IL-8 receptors, CXCR1 and CXCR2 in human malignant melanoma cells with different metastatic potential. CXCR1 and CXCR2 mRNA and protein levels were analyzed by reverse trannscriptase-based polymerase chain reaction, immunohistochemistry, immunoprecipitation, flow cytometry and ligand binding assay in melanoma cells in vitro and xenografted in nude mice. Melanoma cells constitutively expressed CXCR1 and CXCR2 mRNA and protein. Highly metastatic A375SM cells expressed higher levels of CXCR1 and CXCR2 mRNA and protein in vitro and in vivo as compared to low metastatic A375P and non-metastatic SBC-2 melanoma cells. Treatment of SBC-2 and A375P cells with exogenously added recombinant IL-8 significantly enhanced their proliferation and invasive potential. Further neutralizing antibodies to CXCR1 and CXCR2 inhibited proliferation and invasive potential of unstimulated and IL-8-stimulated A375P cells. In summary, the data suggest that constitutive expression of CXCR1 and CXCR2 play an important role regulating the IL-8-mediated metastatic phenotype in human malignant melanoma cells.

Indexed as

AnimalsCell DivisionHumansInterleukin-8MelanomaMiceMice, NudeNeoplasm InvasivenessNeoplasm TransplantationReceptors, Interleukin-8AReceptors, Interleukin-8BInterleukin-8Receptors, Interleukin-8AReceptors, Interleukin-8B

Identifiers

PMID14713106
OpenAlexW2077443884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.